Jpmorgan Chase & CO Inogen Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INGN
# of Institutions
138Shares Held
21.8MCall Options Held
252KPut Options Held
183K-
Camber Capital Management LP Boston, MA2MShares$15.3 Million0.4% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.98MShares$15.2 Million0.29% of portfolio
-
Black Rock Inc. New York, NY1.67MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$10.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.28MShares$9.79 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $175M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...